SUN Orthopedics and Sports Medicine, 900 Buffalo Road, Lewisburg, PA 17837, USA.
Knee Surg Sports Traumatol Arthrosc. 2013 Feb;21(2):346-50. doi: 10.1007/s00167-012-2057-8. Epub 2012 May 25.
Extracorporeal shock wave therapy (SWT) is effective for the management of chronic recalcitrant tendinopathy. The objective of the current study was to assess whether a standardized, single treatment SWT is effective for the management of chronic patellar tendinopathy
Thirty-three patients with chronic patellar tendinopathy received low-energy SWT. Thirty-three patients with chronic patellar tendinopathy received other forms of non-operative therapy (control group). Evaluation was by change in Visual Analogue Scale (VAS), Victoria Institute of Sport Assessment score for patellar tendinopathy (VISA-P) score and by Roles and Maudsley Score.
Mean pre-treatment VAS scores for the control and SWT groups were 7.5 and 7.8, respectively. One month, 3 months, and 12 months after treatment, the mean VAS for the control and SWT groups were 6.7 and 4.3 (p < 0.001), 5.9 and 3.5 (p < 0.001), and 5.1 and 2.7 (p < 0.001), respectively. One month, 3 months, and 12 months after treatment, the mean VISA for the control and SWT groups were 50.7 and 65.5 (p < 0.001), 52.1 and 71 (p < 0.001), and 54.9 and 74.5 (p < 0.001), respectively. At final follow-up, the number of excellent, good, fair, and poor results for the SWT and control groups were 8 and 3 (p < 0.001), 17 and 10 (p < 0.001), 5 and 16 (p < 0.001), and 3 and 4 (p < 0.001), respectively. The percentage of patients with excellent ("1") or good ("2") Roles and Maudsley Scores (i.e. successful results) 12 months after treatment was statistically greater in the SWT group compared to the control group (p < 0.001).
A single application of radial SWT is an effective treatment for chronic patellar tendinopathy.
III.
体外冲击波疗法(SWT)对慢性顽固性肌腱病的治疗有效。本研究的目的是评估标准化单次 SWT 治疗是否对慢性髌腱病的治疗有效。
33 例慢性髌腱病患者接受低能量 SWT 治疗。33 例慢性髌腱病患者接受其他非手术治疗(对照组)。通过视觉模拟量表(VAS)、髌腱病维多利亚运动评估评分(VISA-P)和 Roles 和 Maudsley 评分评估。
对照组和 SWT 组治疗前 VAS 评分分别为 7.5 和 7.8。治疗后 1 个月、3 个月和 12 个月,对照组和 SWT 组的平均 VAS 分别为 6.7 和 4.3(p<0.001)、5.9 和 3.5(p<0.001)、5.1 和 2.7(p<0.001)。治疗后 1 个月、3 个月和 12 个月,对照组和 SWT 组的平均 VISA 分别为 50.7 和 65.5(p<0.001)、52.1 和 71(p<0.001)、54.9 和 74.5(p<0.001)。最终随访时,SWT 组和对照组的优秀、良好、中等和差结果分别为 8 例和 3 例(p<0.001)、17 例和 10 例(p<0.001)、5 例和 16 例(p<0.001)、3 例和 4 例(p<0.001)。治疗后 12 个月,SWT 组患者的优秀(“1”)或良好(“2”)Roles 和 Maudsley 评分(即治疗成功)百分比明显高于对照组(p<0.001)。
单次径向 SWT 应用是治疗慢性髌腱病的有效方法。
III。